Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Well
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Analytics
home
home
Eli Lilly
Eli Lilly
Newsletters
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
By
John Kell
November 19, 2025
Health
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic
By
Nick Lichtenberg
November 6, 2025
Health
Adult obesity rate fell from record high—and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro
By
Matty Merritt
and
Morning Brew
October 31, 2025
Eli Lilly (LLY) Q3 2025 Earnings Call Transcript
By
Fortune Editors
October 30, 2025
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript
By
Fortune Editors
August 7, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Eli Lilly (LLY) Q1 2025 Earnings Call Transcript
By
Fortune Editors
May 1, 2025
Politics
Viagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By
Ryan Hogg
April 30, 2025
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
April 22, 2025
Retail
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
By
Paula Doenecke
,
Naomi Kresge
and
Bloomberg
March 12, 2025
Commentary
The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By
Wendy Barnes
March 4, 2025
Finance
Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By
Madison Muller
and
Bloomberg
February 26, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Ryan Hogg
February 19, 2025
Most Popular
Economy
‘Fodder for a recession’: Top economist Mark Zandi warns about so many Americans ‘already living on the financial edge’...
By
Eva Roytburg
Success
When David Ellison was 13, his billionaire father Larry bought him a plane. He competed in air shows before leaving it...
By
Dave Smith
Banking
Jamie Dimon taps Jeff Bezos, Michael Dell, and Ford CEO Jim Farley to advise JPMorgan's $1.5 trillion national security...
By
Nino Paoli